Drugs & medicalClass I

JB Chemicals and Pharmaceuticals Ltd recalls Cetirizine Hydrochloride Tablets USP 5 mg, 100-count bottle, Manufactured by: Unique Pharmaceuticals Labs, (A Div. of J.B.…

Cross Contamination with Other Products: Customer complaints for appearance of discolored tablets and red dots observed on Cetirizine Hydrochloride Tablets USP 5 mg. Determined to be Ranitidine.

Read the official notice →
Date
2026-07-29
Country
United States
Brand
JB Chemicals and Pharmaceuticals
Product
Cetirizine Hydrochloride Tablets USP 5 mg, 100-count bottle, Manufactured by: Unique Pharmaceuticals Labs, (A Div. of J.B. Chemicals &…
Classification
Class I
Units
Nationwide in the USA
Category
Drugs & medical
Source
FDA · Drug

Copied automatically from the US Food and Drug Administration. Details may be shortened or out of date; the official notice is the authoritative source. Disclaimer

What to do

  1. Check the product name, strength and lot number against the official notice.
  2. Do not stop a prescribed medicine without talking to your doctor or pharmacist first.
  3. Ask the pharmacy or supplier about a replacement or refund.

General guidance from Recall Atlas. The official notice from the US Food and Drug Administration has the exact models, batch codes and remedy, and it takes priority.

More JB Chemicals and Pharmaceuticals recalls

  1. 2026-05-13
  2. US
    Drugs & medicalClass II

    JB Chemicals and Pharmaceuticals Ltd recalls Enalapril Maleate Tablets, USP, 20 mg, 1,000-count bottle, Rx only, Manufactured by: Unique Pharmaceutical Laboratories (A…

    Failed Impurities/Degradation Specifications:Out of specification result occurred in Organic Impurities Test

    FDA · DrugJB Chemicals and Pharmaceuticals LtdNationwide in the USAOfficial notice →
  3. 2025-10-29
  4. US
All 3 JB Chemicals and Pharmaceuticals recalls →

Other drugs & medical recalls in the United States

  1. 2026-07-29
  2. US
  3. US
  4. US
    Drugs & medicalClass III

    Ascend Laboratories, LLC recalls Dabigatran etexilate Capsules, 150 mg, 20-count carton (2x10), Rx only, Manufactured by: Alkem Laboratories, Mumbai, INDIA, Distributed…

    Failed Impurities/Degradation Specifications: OOS result was observed during the related substance test analysis with respect to Impurity II, Impurity III and Total impurity testing for 12 Month Long-Term Stability.

    FDA · DrugAscend Laboratories, LLCUSA NationwideOfficial notice →
  5. US
    Drugs & medicalClass II

    Fresenius Kabi USA, LLC recalls Naropin (ropivacaine hydrochloride Injection, USP), 0.5%, 100 mg per 20 mL (5 mg per mL), Twenty-five, 20 mL Single-Dose Vials, Rx only,…

    Presence of Particulate Matter: Hair was found in products

    FDA · DrugFresenius Kabi USA, LLCNationwide within in the USAOfficial notice →
  6. US
    Drugs & medicalClass II

    Fresenius Kabi USA, LLC recalls Glycopyrrolate Injection, USP, 1 mg per 5 mL (0.2 mg per mL), 25 x 5 mL fill in a 6.5 mL vial, Rx only, Multiple Dose Vials, Fresenius…

    Presence of Particulate Matter: Hair was found in product

    FDA · DrugFresenius Kabi USA, LLCNationwide within in the USAOfficial notice →
  7. US
    Drugs & medicalClass II

    Rising Pharma Holding, Inc. recalls Rising, Cyproheptadine Hydrochloride Syrup, 2mg/5 mL, 473 mL (ONE PINT), Rx only, Manufactured for: Rising Pharma Holdings, Inc.,…

    Presence of Precipitate: medication was crystallizing and particles floating in the bottle

    FDA · DrugRising Pharma Holding, Inc.Nationwide U.S.A.Official notice →
See all drugs & medical recalls →